InspireMD Corp (NSPR) - Net Sales Margin

InspireMD Inc (NSPR) - corporate logo

InspireMD, Inc. (NSPR) is expanding its business by optimizing production through reliable contractors with strict quality control. The sales efficiency metric based on net profit reflects profit dynamics, where the -469.10 mark serves as the current indicator. This reinforces the company's status as a global leader in neurosurgery. The high value of CGuard stents provides InspireMD, Inc. (NSPR) with significant market weight and stable demand for life-saving solutions.

InspireMD Inc. (NSPR) - Return on Sales by Net Profit from 07/04/2022 to 11/19/2026

Financial and market metric breakdowns for InspireMD, Inc. (NSPR)

- share price and expert price forecast:
Summary company analytics:InspireMD Inc. - NSPR
Manufactured product of InspireMD Inc.

Fundamental asset selection requires verifying actual business profitability through operational metrics. This metric measures the share of net profit in every dollar of revenue, identifying systemic degradation or growth in cash flow efficiency. For InspireMD, Inc. (NSPR), with its non-cyclical stent production, this parameter confirms financial stability amid steady demand. Analysis via the net profit margin chart eliminates reporting time lags. The trend on the net profit margin chart allows for an objective assessment of the macro-stability of the company's medical technologies.

Analysis of competing companies

BSX: Net Sales Margin|Return on Sales by Net Profit Edwards Lifesciences Corporation|RMD (ResMed Corporation) - Net Sales Margin|OmniPod (PODD) - Company Sales Margin|Net Sales Margin ZBH|Net Sales Margin coopercos.com (COO)|Net Sales Margin ALGN (aligntech.com)|Net Sales Margin Globus Medical Inc GMED|TMDX - Net Margin|ATEC: Net Margin|AORT (Artivion, Inc.) - Return on Sales by Net Profit|Enovis Corporation - Net Profit Rate|IART (Integra LifeSciences Inc.) - Net Sales Margin|Net Margin Establishment Labs Corp ESTA|Net Margin Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Net Profitability Margin|Embecta Health - Return on Sales by Net Profit|Net Sales Margin Tandem Diabetes Care TNDM|AxoGen Inc - Net Sales Margin|Company Sales Margin SI-BONE Inc SIBN|Orthofix (OFIX) - Net Margin|Return on Sales by Net Profit Bioventus Corp|Net Margin orthopediatrics.com|Return on Sales by Net Profit Treace Medical Concepts (TMCI)|Net Sales Margin SRTA|CARL - Net Margin|Net Margin RxSight, Inc. RXST|CLPT: Net Return on Sales|STXS: Return on Sales by Net Profit|neurostar.com - Company Net Profitability|Sight Sciences Inc. (SGHT) - Net Margin|Net Margin orchestrabiomed.com (OBIO)|Net Margin Anika Therapeutics, Inc.|zhjmedical.com (ZJYL) - Company Sales Margin|Return on Sales by Net Profit VANI (Vivani Medical)|Net Sales Margin Xtant Medical Holdings, Inc. (XTNT)|Net Margin NeuroOne Medical Technologies Corporation NMTC|Net Sales Margin Modular Medical MODD|MYO: Return on Sales by Net Profit|Net Margin Envoy Medical, Inc.|VVOS (Vivos Therapeutics) - Return on Sales by Net Profit|Net Return on Sales NVNO|Return on Sales by Net Profit SINT|Return on Sales by Net Profit Tenon Medical (TNON)|Net Margin ReWalk Robotics Ltd (LFWD)|Company Sales Margin Autonomix|Net Sales Margin IVF (invobioscience.com)|bonebiologics.com - Net Margin|AXNX - Net Margin|BIOL (BIOLASE) - Net Return on Sales|Dynatronics Corporation (DYNT) - Net Margin|Net Return on Sales FNA|INVO (INVO Bioscience Inc.) - Net Sales Margin